ANXIOGENIC-LIKE EFFECT OF GLYCINE AND D-SERINE MICROINJECTED INTO DORSAL PERIAQUEDUCTAL GRAY-MATTER OF RATS

被引:37
作者
SCHMITT, ML
COELHO, W
LOPESDESOUZA, AS
GUIMARAES, FS
CAROBREZ, AP
机构
[1] UNIV FED SANTA CATARINA, CCB, DEPT FARMACOL, BR-88015420 FLORIANOPOLIS, SC, BRAZIL
[2] UNIV SAO PAULO, FAC MED RIBEIRAO PRETO, DEPT FARMACOL, RIBEIRAO PRETO, BRAZIL
关键词
PERIAQUEDUCTAL GRAY; GLYCINE N-METHYL-D-ASPARTATE RECEPTORS; ANXIETY; EXCITATORY AMINO ACIDS; ELEVATED PLUS-MAZE; RAT;
D O I
10.1016/0304-3940(95)11459-A
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The glutamatergic system of the dorsal periaqueductal gray matter (DPAG) has been implicated in anxiety. This study shows that microinjections of glycine (GLY) or D-serine (D-SER), into the DPAG of rats, dose-dependently reduced the number of entries and the time spent on open arms of an elevated plus-maze (EPM), an established animal model for measuring anxiety-related behavior. This anxiogenic-like effect was greatest following DPAG application of either 80 nmol GLY or 160 and 320 nmol D-SER. Microinjections of these same amino acid doses outside the DPAG, or of L-serine (320 nmol) inside the DPAG, produced neither of these pro-anxiety effects, The current results suggest that, in vivo, the GLY modulatory site of N-methyl-D-asparate receptors is not fully saturated, and further substantiate a role for the DPAG excitatory amino acid system in anxiety.
引用
收藏
页码:93 / 96
页数:4
相关论文
共 28 条
[1]   ANXIOLYTIC-LIKE EFFECTS OF N-METHYL-D-ASPARTATE-ASSOCIATED GLYCINE RECEPTOR LIGANDS IN THE RAT POTENTIATED STARTLE TEST [J].
ANTHONY, EW ;
NEVINS, ME .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (02) :317-324
[2]   ELICITATION OF INTRASPECIFIC DEFENSE REACTIONS IN THE RAT FROM MIDBRAIN PERIAQUEDUCTAL GREY BY MICROINJECTION OF KAINIC ACID, WITHOUT NEUROTOXIC EFFECTS [J].
BANDLER, R ;
DEPAULIS, A .
NEUROSCIENCE LETTERS, 1988, 88 (03) :291-296
[4]  
BATISTADASILVA AP, 1990, BRAZ J MED BIOL RES, V23, P705
[5]  
BENNETT DA, 1987, EXCITATORY AMINO ACI, P213
[6]  
BLANCHARD DC, 1992, PSYCHOPHARMACOLOGY, V108, P352
[7]  
COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143
[8]   EFFECTS OF HA-966 ON CONFLICT, SOCIAL-INTERACTION, AND PLUS MAZE BEHAVIORS [J].
CORBETT, R ;
DUNN, RW .
DRUG DEVELOPMENT RESEARCH, 1991, 24 (03) :201-205
[9]  
Graeff FG, 1990, HDB ANXIETY, V3, P307
[10]  
GRAEFF FG, 1988, NEUROL NEUR, V46, P325